Related Experiment Videos
Retrolental fibroplasia today
The Medical Journal of Australia
|March 21, 1981
Summary
Retinopathy of prematurity (RLF) is rising in premature infants. Despite advanced monitoring, hyperoxia remains a significant risk factor for this condition.
Area of Science:
- Neonatal ophthalmology
- Perinatal medicine
Background:
- Increasing survival rates of premature infants, particularly those with low birth weight, have led to a rise in retrolental fibroplasia (RLF), also known as retinopathy of prematurity.
- RLF affects approximately 17% of at-risk premature neonates, though most cases resolve spontaneously.
Purpose of the Study:
- To review current knowledge and management strategies for retinopathy of prematurity (RLF).
- To emphasize the persistent challenges posed by hyperoxia in RLF, even with advanced monitoring techniques.
Main Methods:
- Literature review of current knowledge on RLF.
- Analysis of RLF incidence and outcomes in premature neonates.
- Discussion of hyperoxia as a contributing factor.
Main Results:
- The incidence of RLF is increasing due to improved survival rates in premature infants.
- A significant percentage of at-risk infants develop RLF, but spontaneous resolution is common.
- Advanced monitoring has not eradicated the risks associated with hyperoxia.
Conclusions:
- Effective management of RLF requires continued vigilance regarding hyperoxia.
- Further research into preventing and managing RLF in premature infants is warranted.
- The interplay between prematurity, oxygen management, and RLF necessitates a comprehensive approach.